157 related articles for article (PubMed ID: 12815593)
1. A phylogenetic approach to assessing the significance of missense mutations in disease genes.
Santibáñez Koref MF; Gangeswaran R; Santibáñez Koref IP; Shanahan N; Hancock JM
Hum Mutat; 2003 Jul; 22(1):51-8. PubMed ID: 12815593
[TBL] [Abstract][Full Text] [Related]
2. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
Greenblatt MS; Beaudet JG; Gump JR; Godin KS; Trombley L; Koh J; Bond JP
Oncogene; 2003 Feb; 22(8):1150-63. PubMed ID: 12606942
[TBL] [Abstract][Full Text] [Related]
3. Selective pressures at a codon-level predict deleterious mutations in human disease genes.
Arbiza L; Duchi S; Montaner D; Burguet J; Pantoja-Uceda D; Pineda-Lucena A; Dopazo J; Dopazo H
J Mol Biol; 2006 May; 358(5):1390-404. PubMed ID: 16584746
[TBL] [Abstract][Full Text] [Related]
4. Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods.
Mathe E; Olivier M; Kato S; Ishioka C; Hainaut P; Tavtigian SV
Nucleic Acids Res; 2006; 34(5):1317-25. PubMed ID: 16522644
[TBL] [Abstract][Full Text] [Related]
5. The IARC TP53 database: new online mutation analysis and recommendations to users.
Olivier M; Eeles R; Hollstein M; Khan MA; Harris CC; Hainaut P
Hum Mutat; 2002 Jun; 19(6):607-14. PubMed ID: 12007217
[TBL] [Abstract][Full Text] [Related]
6. The impact of p53 protein core domain structural alteration on ovarian cancer survival.
Rose SL; Robertson AD; Goodheart MJ; Smith BJ; DeYoung BR; Buller RE
Clin Cancer Res; 2003 Sep; 9(11):4139-44. PubMed ID: 14519637
[TBL] [Abstract][Full Text] [Related]
7. The UMD TP53 database and website: update and revisions.
Hamroun D; Kato S; Ishioka C; Claustres M; Béroud C; Soussi T
Hum Mutat; 2006 Jan; 27(1):14-20. PubMed ID: 16278824
[TBL] [Abstract][Full Text] [Related]
8. A highly sensitive detection method for somatic mutations in p53 gene.
Sato T; Sato A; Ishihara H; Konishi K
Rinsho Byori; 2003 Feb; 51(2):98-106. PubMed ID: 12690626
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features.
Walker DR; Bond JP; Tarone RE; Harris CC; Makalowski W; Boguski MS; Greenblatt MS
Oncogene; 1999 Jan; 18(1):211-8. PubMed ID: 9926936
[TBL] [Abstract][Full Text] [Related]
10. Structural assessment of single amino acid mutations: application to TP53 function.
Yip YL; Zoete V; Scheib H; Michielin O
Hum Mutat; 2006 Sep; 27(9):926-37. PubMed ID: 16917930
[TBL] [Abstract][Full Text] [Related]
11. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Kato S; Han SY; Liu W; Otsuka K; Shibata H; Kanamaru R; Ishioka C
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8424-9. PubMed ID: 12826609
[TBL] [Abstract][Full Text] [Related]
12. Time for a unified system of mutation description and reporting: a review of locus-specific mutation databases.
Claustres M; Horaitis O; Vanevski M; Cotton RG
Genome Res; 2002 May; 12(5):680-8. PubMed ID: 11997335
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations.
Thusberg J; Vihinen M
Hum Mutat; 2006 Dec; 27(12):1230-43. PubMed ID: 16986121
[TBL] [Abstract][Full Text] [Related]
14. Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic disease.
Terp BN; Cooper DN; Christensen IT; Jørgensen FS; Bross P; Gregersen N; Krawczak M
Hum Mutat; 2002 Aug; 20(2):98-109. PubMed ID: 12124990
[TBL] [Abstract][Full Text] [Related]
15. Bayesian approach to discovering pathogenic SNPs in conserved protein domains.
Cai Z; Tsung EF; Marinescu VD; Ramoni MF; Riva A; Kohane IS
Hum Mutat; 2004 Aug; 24(2):178-84. PubMed ID: 15241800
[TBL] [Abstract][Full Text] [Related]
16. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance.
Caligo MA; Bonatti F; Guidugli L; Aretini P; Galli A
Hum Mutat; 2009 Jan; 30(1):123-33. PubMed ID: 18680205
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution.
Pybus OG; Rambaut A; Belshaw R; Freckleton RP; Drummond AJ; Holmes EC
Mol Biol Evol; 2007 Mar; 24(3):845-52. PubMed ID: 17218639
[TBL] [Abstract][Full Text] [Related]
19. Predicting the oncogenicity of missense mutations reported in the International Agency for Cancer Research (IARC) mutation database on p53.
Gorlov IP; Gorlova OY; Amos CI
Hum Mutat; 2005 Nov; 26(5):446-54. PubMed ID: 16173033
[TBL] [Abstract][Full Text] [Related]
20. [Genetic variations of the tumor suppressor TP53: outstanding and strategies of analysis].
Rangel-López A; Piña-Sánchez P; Salcedo M
Rev Invest Clin; 2006; 58(3):254-64. PubMed ID: 16958302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
